Bioengineering professor and The Grainger College of Engineering's Dean, Rashid Bashir, led a team of researchers in a project that's resulted in new ...
(AIM: 4BB) is an innovation driven life biotechnology company focused on accelerating the development of advanced therapy medicinal products (ATMPs) through its high-performance synthetic DNA products ...
Bioengineering professor and The Grainger College of Engineering’s Dean, Rashid Bashir, led a team of researchers in a project that’s resulted in new technology that offers rapid, highly sensitive det ...
University of Illinois at Urbana-Champaign researchers have developed a CRISPR-based diagnostic tool capable of detecting ...
Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of ...
BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...
Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic ...
In a preclinical study, researchers at Children's Hospital of Philadelphia (CHOP) demonstrated a novel gene therapy with ...
Shortly after this publication, Bogdanove struck up a collaboration with Daniel Voytas, a plant geneticist at the University ...
In the pursuit of understanding the pathogenic expression mechanisms of bacteria and the advancements in biofoundry ...
Employee Long Term Incentive Plan and Issue of Equity. Cambridge, UK, 7 March 2025 - 4basebio PLC (AIM: 4BB), an innovation-led provider ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback